Monopar Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
· manilatimes.net
WILMETTE, Ill., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. ('Monopar” or the 'Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced second quarter 2026 financial results and provided business updates.
WILMETTE, Ill., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. ("Monopar” or the "Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutica...